Company / Total Assets
Cullinan Therapeutics, Inc. Total Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$621.8M
FY2024
5-year range
$214.7M / $621.8M
FY2020-FY2024
Trend
+28.4%
vs FY2023
Sector context
#120 of 214
Health Care
What the data says
At $622M, Cullinan Therapeutics, Inc.'s total assets ranks #120 of 214 in the Health Care sector. Improved from $561M to $622M over the past 2 years.
Based on SEC 10-K filings.
$622M in FY2024 with a 3-year CAGR of +12.5%.
Improved from $561M to $622M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +12.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 214 in Health CareTop 56% of 214This company $621.8M Sector average $7.5B
▼
-91.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +12.5%, indicating consistent growth.
- In FY2024, total assets increased 28.4% year-over-year.
- Ranks #120 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $621.8M | +28.4% |
| FY2023 | $484.2M | -13.7% |
| FY2022 | $561.1M | +28.3% |
| FY2021 | $437.2M | +103.6% |
| FY2020 | $214.7M | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026